DAVID P. LUCI - 19 Nov 2021 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: David P. Luci
Issuer symbol
ACXP
Transactions as of
19 Nov 2021
Transactions value $
$24,960
Form type
4
Filing time
22 Nov 2021, 15:05:34 UTC
Previous filing
06 Jul 2021
Next filing
29 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Purchase $24,960 +5,200 +0.52% $4.8 1,008,723 19 Nov 2021 Direct
holding ACXP Common Stock 15,083 19 Nov 2021 By spouse
holding ACXP Common Stock 35,000 19 Nov 2021 By child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.